ToolGen files patent infringement lawsuit against Lonza in the Netherlands: Seoul, Republic of Korea Tuesday, September 9, 2025, 18:00 Hrs [IST] ToolGen, a leader in gene editing ...

CRISPR Therapeutics CRSP and Beam Therapeutics BEAM are leading developers of therapies that utilize the Nobel Prize-winning ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $5.0, a high estimate of $6.00, ...

CRISPR Therapeutics CRSP is the first and only company in the world to market a CRISPR/Cas9-based therapy. The company tasted ...

Scientists have used CRISPR-Cas9 technology to develop therapies for genetic disorders relatively easily and cost-effectively. In this article, explore the milestones in CRISPR therapy development, ...

CRISPR Cas9 Technology and the Promise of " In-Vivo " Briefly Explained Obviously, CRISPR/Cas9 gene editing is the cornerstone of CRISPR Therapeutics's business.

The integration of CRISPR/Cas9 technology into live cell imaging represents a significant leap forward in genomic research.

Several approaches involve using CRISPR- Cas9 technology to change pathogenic gene alleles into healthy ones or to engineer cells that secrete therapeutic cytokines in response to inflammatory ...

The authors of this article review recent applications of CRISPR-Cas9-based gene editing technology in mosquito-borne disease prevention and control, as well as mosquito population suppression ...

Acting like molecular scissors, the CRISPR/Cas9 technology uses proteins to target specific DNA sequences in a person's genetic code, precisely addressing diseases caused by genetic mutations.